Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chaemin Lim

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Nanomedicine : Nanotechnology, Biology, and Medicine|December 1, 2020
Poly(2-oxazoline) nanoparticle delivery enhances the therapeutic potential of vismodegib for medulloblastoma by improving CNS pharmacokinetics and reducing systemic toxicityDuhyeong Hwang, Taylor Dismuke, Andrey Tikunov, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2026
Nanoparticle-delivered resiquimod induces brain tumor regression in medulloblastoma and diffuse midline glioma models by interrupting paracrine growth support and activating myeloid immune signaling and phagocytosisLeon McSwain, Kyongtea Kim, Duhyeong Hwang, et al.
The Journal of Pharmacy and Pharmacology|September 6, 2017
Characterization and pharmacokinetic study of itraconazole solid dispersions prepared by solvent-controlled precipitation and spray-dry methodsTaehoon Sim, Chaemin Lim, Jun Won Lee, et al.
Nano Today|July 24, 2023
High-Dose Paclitaxel and its Combination with CSF1R Inhibitor in Polymeric Micelles for Chemoimmunotherapy of Triple Negative Breast CancerChaemin Lim, Duhyeong Hwang, Mostafa Yazdimamaghani, et al.
Archives of Pharmacal Research|March 8, 2011
Identification and evaluation of neutral sphingomyelinase 2 inhibitorsDong Hun Lee, Sung Hyun Kim, Kyong Hoon Ahn, et al.
Journal of Advanced Research|February 14, 2025
Blocking S1P<sub>4</sub> signaling attenuates brain injury in mice with ischemic strokeNikita Basnet, Hyunkyung Cho, Arjun Sapkota, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 10, 2025
Extracellular vesicle as therapeutic agents in anti-aging: Mechanistic insights and future potentialHyejoo Yoon, Junyeong Jo, Hyesun Hyun, et al.
Drug Delivery|June 6, 2018
Development of a docetaxel micellar formulation using poly(ethylene glycol)-polylactide-poly(ethylene glycol) (PEG-PLA-PEG) with successful reconstitution for tumor targeted drug deliveryTaehoon Sim, Jae Eun Kim, Ngoc Ha Hoang, et al.
ACS Medicinal Chemistry Letters|December 30, 2015
Structure-Activity Study of Bioisosteric Trifluoromethyl and Pentafluorosulfanyl Indole Inhibitors of the AAA ATPase p97Celeste Alverez, Michelle R Arkin, Stacie L Bulfer, et al.
Biomaterials|October 11, 2021
Bioequivalence assessment of high-capacity polymeric micelle nanoformulation of paclitaxel and Abraxane® in rodent and non-human primate models using a stable isotope tracer assayDuhyeong Hwang, Natasha Vinod, Sarah L Skoczen, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Nanomedicine : Nanotechnology, Biology, and Medicine|December 1, 2020
Poly(2-oxazoline) nanoparticle delivery enhances the therapeutic potential of vismodegib for medulloblastoma by improving CNS pharmacokinetics and reducing systemic toxicityDuhyeong Hwang, Taylor Dismuke, Andrey Tikunov, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2026
Nanoparticle-delivered resiquimod induces brain tumor regression in medulloblastoma and diffuse midline glioma models by interrupting paracrine growth support and activating myeloid immune signaling and phagocytosisLeon McSwain, Kyongtea Kim, Duhyeong Hwang, et al.
The Journal of Pharmacy and Pharmacology|September 6, 2017
Characterization and pharmacokinetic study of itraconazole solid dispersions prepared by solvent-controlled precipitation and spray-dry methodsTaehoon Sim, Chaemin Lim, Jun Won Lee, et al.
Nano Today|July 24, 2023
High-Dose Paclitaxel and its Combination with CSF1R Inhibitor in Polymeric Micelles for Chemoimmunotherapy of Triple Negative Breast CancerChaemin Lim, Duhyeong Hwang, Mostafa Yazdimamaghani, et al.
Archives of Pharmacal Research|March 8, 2011
Identification and evaluation of neutral sphingomyelinase 2 inhibitorsDong Hun Lee, Sung Hyun Kim, Kyong Hoon Ahn, et al.
Journal of Advanced Research|February 14, 2025
Blocking S1P<sub>4</sub> signaling attenuates brain injury in mice with ischemic strokeNikita Basnet, Hyunkyung Cho, Arjun Sapkota, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 10, 2025
Extracellular vesicle as therapeutic agents in anti-aging: Mechanistic insights and future potentialHyejoo Yoon, Junyeong Jo, Hyesun Hyun, et al.
Drug Delivery|June 6, 2018
Development of a docetaxel micellar formulation using poly(ethylene glycol)-polylactide-poly(ethylene glycol) (PEG-PLA-PEG) with successful reconstitution for tumor targeted drug deliveryTaehoon Sim, Jae Eun Kim, Ngoc Ha Hoang, et al.
ACS Medicinal Chemistry Letters|December 30, 2015
Structure-Activity Study of Bioisosteric Trifluoromethyl and Pentafluorosulfanyl Indole Inhibitors of the AAA ATPase p97Celeste Alverez, Michelle R Arkin, Stacie L Bulfer, et al.
Biomaterials|October 11, 2021
Bioequivalence assessment of high-capacity polymeric micelle nanoformulation of paclitaxel and Abraxane® in rodent and non-human primate models using a stable isotope tracer assayDuhyeong Hwang, Natasha Vinod, Sarah L Skoczen, et al.
Pageof 7